Greenleaf Peter Insider Trading -- Recent SEC Form 4 Transactions
Greenleaf Peter (CIK 1363683) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-10-06). Recent activity: Sell PTHS (797 shares), Sell PTHS (712 shares), Sell PTHS (85 shares), Sell PTHS (377 shares), Sell PTHS (420 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 797 | $16,872 |
| 2026-07-07 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 712 | $18,509 |
| 2026-07-07 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 85 | $2,318 |
| 2026-04-06 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 377 | $8,053 |
| 2026-04-06 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 420 | $8,618 |
| 2026-04-01 | Pelthos Therapeutics Inc. (PTHS) | Director | Buy | 25,478 | $0 |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Buy | 196,403 | $0 |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Sell | 100,890 | $1.4M |
| 2026-02-23 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Sell | 100,171 | $1.4M |
| 2026-01-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Buy | 165,384 | $0 |
| 2026-01-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Sell | 113,169 | $1.8M |
Source: SEC Form 4 filings · as of 2026-10-06